Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-18 | New | $34,333,315 | $34,333,315 | Debt Only | 06b | SEC link |
| 2022-07-25 | New | $224,999,876 | $224,999,876 | Equity Only | 06b | SEC link |
| 2021-01-27 | New | $101,074,986 | $101,074,986 | Equity Only | 06b | SEC link |
| 2019-08-27 | New | $5,500,000 | $5,500,000 | Equity Only | 06b | SEC link |
| 2019-08-13 | New | $15,343 | $15,343 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Peter B. Bach | Executive |
| Jennifer Buechel | Executive |
| Nicholas Dracopoli | Executive |
| Michael Dybbs | Director |
| Rishi Gupta | Director |
| Elizabeth Homans | Director |
| Justin Kao | Director |
| Douglas Schenkel | Executive |
| Amoolya Singh | Executive |
| Lee Ann Smith Freeman | Executive |
| William Stevens | Executive |
| Susan Tousi | Director, Executive |
| Jacob Van Naarden | Director |
| Victor Velculescu | Director |
| Greg Yap | Director |